This product is a bisphosphonate bone resorption inhibitor, which may mainly produce anti-bone resorption effect by binding to hydroxyapatite in the bone, inhibiting the dissolution and formation of hydroxyapatite.

Fluconazole is a new triazole antifungal drug with a broad-spectrum antifungal effect and can selectively inhibit fungal sterol synthesis. It is effective against Candida infections, Cryptococcus neoformans infections, Malassezia sacchari, Microsporum, Trichophyton, Epidermophyton, Blastomyces dermatitidis, Coccidioides immitis, Histoplasma capsulatum, Peyer's Chromatids, and Cladosporium carinii. It has a highly selective inhibitory effect on fungal cytochrome p-450-dependent enzymes. Studies have shown that taking fluconazole has no effect on male plasma testosterone concentrations or plasma steroid concentrations in women of childbearing age, no significant effect on endogenous steroid levels or adrenocorticotropic hormone effects in healthy male volunteers, and no effect on the metabolism of antipyrine.

Quinolone antibiotics inhibit bacterial DNA gyrase activity and bacterial DNA replication, and have broad-spectrum and strong antibacterial effects. They have good antibacterial effects on Enterobacteriaceae, Staphylococcus, Streptococcus pneumoniae, Haemophilus influenzae, Pseudomonas aeruginosa, gonococci, Chlamydia, etc.

This product belongs to the quinolone antibacterial drug, which is the levorotatory form of ofloxacin. Its antibacterial activity is about twice that of ofloxacin. Its main mechanism of action is to inhibit the activity of bacterial DNA gyrase and the replication of bacterial DNA. It has the characteristics of broad antibacterial spectrum and strong antibacterial effect, and has good antibacterial effect on most Enterobacteriaceae, some Staphylococci, Streptococcus pneumoniae, Haemophilus influenzae, Pseudomonas aeruginosa, Neisseria gonorrhoeae, Chlamydia, etc.

Quinolone antibiotics inhibit bacterial DNA gyrase activity and bacterial DNA replication; they have good antibacterial effects on Enterobacteriaceae, Staphylococcus, Streptococcus pneumoniae, Haemophilus influenzae, Pseudomonas aeruginosa, Neisseria gonorrhoeae, Chlamydia, etc.